Trial
NCT03353428
Intervention of Engineered Immune Effector T Cells Against Lung Cancer
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Shenzhen Geno-Immune Medical Institute
Collaborators
—
Condition
Lung Cancer
Intervention
LC-CTLs
Why stopped
combine with NCT03356808
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-23